Connect with us

Press Releases

Circularix Expands Recycled PET Production With New Florida Facility and Pennsylvania Capacity Increase

New facility doubles the company’s capacity, with planned expansion of its existing Pennsylvania plant tripling current output.

mm

Published

on

(PRESS RELEASE) LOS ANGELES — Circularix, a leading producer of food-grade recycled PET (rPET), announced its second production facility, located in Ocala, Florida, is set to begin operations by the end of Q1 2025, marking a significant milestone in the company’s expansion plans.

The new Florida location mirrors Circularix’s existing Pennsylvania facility, which has been operational since early 2023. This strategic expansion will effectively double the company’s production capacity, with each facility capable of producing 55 million pounds of food-grade, post-consumer rPET pellets annually.

Jason Farahnik, Co-Founder and EVP, stated, “The completion of our Ocala facility represents a crucial step in our commitment to meeting the growing demand for high-quality recycled materials. This expansion aligns with our goal of helping companies achieve their sustainability objectives. We also plan to double capacity at our Pennsylvania facility later this year, bringing our total production to 165 million pounds, tripling our current output.”

The new facility is part of Circularix’s broader strategy to establish a network of recycling facilities across the United States. Future locations are planned for Texas and West Coast states, further solidifying Circularix’s position as a key player in the domestic rPET market.

This expansion comes at a critical time as beverage brands and consumer packaged goods companies work to increase recycled content in their packaging to meet voluntary commitments and state mandates. Circularix’s increased production capacity will play a vital role in helping these companies meet their sustainability goals and contribute to a more sustainable plastics economy.

For more information about Circularix and its commitment to advancing plastics recycling, please visit here.

Advertisement

Advertisement

FEATURED VIDEO

Sponsored by Cogent Solutions Group

Reduce Your Pet’s Hip & Joint Discomfort with the Most Researched Hyaluronan on the Market

Nearly 60% of dogs and 90% of cats suffer from joint discomfort. Trixsyn joint supplement contains a patented and proven hyaluronic acid molecule for maximum efficacy to promote joint, bone, soft tissue, and cartilage health, keeping your pet feeling comfortable, for longer. Trixsyn is veterinarian recommended, safe and all-natural, and contains research-proven ingredients. Get your paws on the most-researched hyaluronic acid on the market. Learn more at Trixsyn.com.

Promoted Headlines

Most Popular